EKR Therapeutics names John Bailye executive chairman

BEDMINSTER, N.J. A privately held specialty pharmaceutical company announced that the founder and former chairman of Dendrite International has joined its company.

EKR Therapeutics said John Bailye has been elected to its board of directors as executive chairman.

“John Bailye is a forward thinker who possesses exceptional knowledge of the pharmaceutical industry, and we are all very pleased to welcome John to the Board and the EKR management team,” EKR co-founder and CEO Howard Weisman.

In other news, Weisman will now also actively serve as president; thereby, focusing greater corporate resources on the day-to-day operations of the company’s rapidly expanding business.